Forward Pharma A/S Share · US34986J3032 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Forward Pharma A/S
No Price
Company Profile for Forward Pharma A/S Share
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
Company Data
Name Forward Pharma A/S
Company Forward Pharma A/S
Website
https://www.forward-pharma.com
Primary Exchange 
UTC
UTC
ISIN US34986J3032
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Claus Bo Søndergaard Svendsen
Country Denmark
Currency USD
Employees 0,0 T
Address Oestergade 24A, 1100 Copenhagen
IPO Date 2014-10-15
Dividends from 'Forward Pharma A/S'
| Ex-Date | Dividend per Share |
|---|---|
| 12.09.2017 | 23,07 USD |
Stock Splits
| Date | Split |
|---|---|
| 08.06.2023 | 1:285.714 |
| 06.12.2019 | 1:7 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | FWPAY |
More Shares
Investors who hold Forward Pharma A/S also have the following shares in their portfolio:
